Back to top
more

Insulet Corporation (PODD)

(Delayed Data from NSDQ)

$282.45 USD

282.45
514,985

+0.85 (0.30%)

Updated Jun 11, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (191 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for PODD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Insulet Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 948 376 289 440 299
Receivables 84 83 77 53 29
Notes Receivable 0 0 0 0 0
Inventories 154 101 71 34 36
Other Current Assets 63 31 24 10 7
Total Current Assets 1,249 591 461 537 370
Net Property & Equipment 479 399 258 108 46
Investments & Advances 0 58 141 126 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 69 53 50 44 40
Deposits & Other Assets 77 41 18 2 0
Total Assets 1,873 1,143 929 817 457
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 54 55 26 24 13
Current Portion Long-Term Debt 16 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 138 103 89 59 41
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 1 2 1
Total Current Liabilities 208 158 116 86 56
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 888 0 0 0
Long-Term Debt 1,044 0 592 566 333
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 18 21 9 6 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,269 1,067 717 658 394
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,264 749 899 866 744
Retained Earnings -666 -672 -684 -707 -680
Other Equity 6 -1 -3 -0 -1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 604 76 212 159 63
Total Liabilities & Shareholder's Equity 1,873 1,143 929 817 457
Total Common Equity 604 76 212 159 63
Shares Outstanding 65.90 61.80 59.00 58.10 57.40
Book Value Per Share 9.16 1.23 3.59 2.73 1.10

Fiscal Year End for Insulet Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 850 948 897 844 322
Receivables 98 84 85 78 80
Notes Receivable 0 0 0 0 0
Inventories 170 154 125 104 96
Other Current Assets 74 63 53 60 44
Total Current Assets 1,192 1,249 1,160 1,086 541
Net Property & Equipment 498 479 449 423 412
Investments & Advances 0 0 1 24 61
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 70 69 50 51 52
Deposits & Other Assets 81 77 50 44 42
Total Assets 1,840 1,873 1,711 1,627 1,108
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 59 54 57 36 36
Current Portion Long-Term Debt 16 16 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 111 138 118 99 94
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 186 208 175 134 130
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 922 910 899
Long-Term Debt 1,052 1,044 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 18 19 19 20
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,255 1,269 1,116 1,063 1,049
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,248 1,264 1,245 1,228 738
Retained Earnings -666 -666 -649 -661 -675
Other Equity 3 6 -1 -4 -4
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 585 604 595 563 59
Total Liabilities & Shareholder's Equity 1,840 1,873 1,711 1,627 1,108
Total Common Equity 585 604 595 563 59
Shares Outstanding 66.20 65.90 65.90 65.60 63.00
Book Value Per Share 8.84 9.16 9.03 8.59 0.94